Short Interest in Arteris, Inc. (NASDAQ:AIP) Expands By 7.0%

Arteris, Inc. (NASDAQ:AIP) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 712,600 shares, an increase of 7.0% from the September 15th total of 666,000 shares. Currently, 3.0% of the shares of the company are sold short. Based on an average trading volume of 131,500 shares, the days-to-cover ratio is presently 5.4 days.

Arteris Price Performance

Shares of NASDAQ:AIP opened at $7.37 on Thursday. The company has a market capitalization of $283.59 million, a PE ratio of -7.16 and a beta of 1.11. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.14 and a current ratio of 1.14. The stock has a fifty day moving average of $7.50 and a 200-day moving average of $7.65. Arteris has a one year low of $4.20 and a one year high of $9.54.

Arteris (NASDAQ:AIP) last announced its earnings results on Thursday, August 1st. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.07). Arteris had a negative net margin of 68.37% and a negative return on equity of 274.66%. The company had revenue of $14.58 million for the quarter, compared to analysts’ expectations of $13.68 million. During the same period in the prior year, the company earned ($0.25) earnings per share. As a group, equities analysts anticipate that Arteris will post -0.9 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Westpark Capital reissued a “buy” rating and issued a $11.00 price objective on shares of Arteris in a research note on Wednesday, July 31st. Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 price target on shares of Arteris in a research report on Monday, August 5th.

Insider Activity at Arteris

In other Arteris news, CFO Nicholas B. Hawkins sold 4,958 shares of the business’s stock in a transaction on Friday, October 4th. The stock was sold at an average price of $7.13, for a total transaction of $35,350.54. Following the completion of the transaction, the chief financial officer now owns 211,713 shares in the company, valued at approximately $1,509,513.69. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Arteris news, CFO Nicholas B. Hawkins sold 4,958 shares of the business’s stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $7.13, for a total transaction of $35,350.54. Following the sale, the chief financial officer now directly owns 211,713 shares in the company, valued at approximately $1,509,513.69. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Wayne C. Cantwell sold 15,000 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $6.95, for a total transaction of $104,250.00. Following the completion of the sale, the director now directly owns 243,198 shares of the company’s stock, valued at approximately $1,690,226.10. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 135,360 shares of company stock worth $988,781 in the last three months. 33.70% of the stock is owned by company insiders.

Institutional Trading of Arteris

A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Arteris by 0.3% during the first quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company’s stock valued at $8,390,000 after acquiring an additional 3,242 shares during the period. Silvercrest Asset Management Group LLC grew its position in Arteris by 25.2% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 711,903 shares of the company’s stock worth $5,211,000 after purchasing an additional 143,385 shares in the last quarter. Acadian Asset Management LLC raised its stake in Arteris by 28.1% during the 1st quarter. Acadian Asset Management LLC now owns 534,472 shares of the company’s stock valued at $3,911,000 after purchasing an additional 117,312 shares during the period. Essex Investment Management Co. LLC purchased a new stake in Arteris in the 3rd quarter worth about $2,504,000. Finally, GSA Capital Partners LLP boosted its position in Arteris by 26.9% during the 1st quarter. GSA Capital Partners LLP now owns 132,952 shares of the company’s stock worth $973,000 after acquiring an additional 28,165 shares during the period. 64.36% of the stock is owned by hedge funds and other institutional investors.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.